In patients with migraine, it is theorized that the trigeminal nerve axons are abnormally activated, leading to the release of neurotransmitters including calcitonin gene-related peptide (CGRP) and substance P (SP), neurokinin A, and nitrous oxide. This evidence concerns the gene TFF2 and migraine disorder.